| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002507 | American Journal of Ophthalmology | 2014 | 9 Pages |
Abstract
BEB may participate in the progress of inflammation in DEDÂ + BEB patients. Botulinum neurotoxin type A injections could effectively relieve the symptoms of DEDÂ + BEB patients and improve their ocular surface condition.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Rong Lu, Ruisheng Huang, Kang Li, Xinchun Zhang, Hui Yang, Yadan Quan, Qian Li,